VanEck Pharmaceutical ETF
PPH
PPH
50 hedge funds and large institutions have $71M invested in VanEck Pharmaceutical ETF in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
32% less capital invested
Capital invested by funds: $105M → $71M (-$33.9M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $313K
Holders
50
Holding in Top 10
–
Calls
–
Puts
$313K
Top Buyers
| 1 | +$2.54M | |
| 2 | +$969K | |
| 3 | +$962K | |
| 4 |
VF
Virtu Financial
New York
|
+$804K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$363K |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$20.7M | |
| 3 | -$800K | |
| 4 |
CCT
Country Club Trust
Kansas City,
Missouri
|
-$688K |
| 5 |
Morgan Stanley
New York
|
-$670K |